Display options
Cite
Abusamra A, Murshid E, Kushi H, et al. Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer. Urol Ann. 2016;8(2):123-30doi: 10.4103/0974-7796.176872.
Abusamra, A., Murshid, E., Kushi, H., Alkhateeb, S., Al-Mansour, M., Saadeddin, A., Rabah, D., Bazarbashi, S., Alotaibi, M., Alghamdi, A., Alghamdi, K., Alsharm, A., & Ahmad, I. (2016). Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer. Urology annals, 8(2), 123-30. https://doi.org/10.4103/0974-7796.176872
Abusamra, Ashraf, et al. "Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer." Urology annals vol. 8,2 (2016): 123-30. doi: https://doi.org/10.4103/0974-7796.176872
Abusamra A, Murshid E, Kushi H, Alkhateeb S, Al-Mansour M, Saadeddin A, Rabah D, Bazarbashi S, Alotaibi M, Alghamdi A, Alghamdi K, Alsharm A, Ahmad I. Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer. Urol Ann. 2016 Apr-Jun;8(2):123-30. doi: 10.4103/0974-7796.176872. PMID: 27141178; PMCID: PMC4839225.
Copy Download .nbib Format: NLM
Share it on

Urol Ann. 2016 Apr-Jun;8(2):123-30. doi: 10.4103/0974-7796.176872.

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.

Urology annals

Ashraf Abusamra, Esam Murshid, Hussain Kushi, Sultan Alkhateeb, Mubarak Al-Mansour, Ahmad Saadeddin, Danny Rabah, Shouki Bazarbashi, Mohammed Alotaibi, Abdullah Alghamdi, Khalid Alghamdi, Abdullah Alsharm, Imran Ahmad

Affiliations

  1. Department of Surgery, Urology Section, King Khalid Hospital, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  2. Department of Oncology, Oncology Center, Prince Sultan Medical Military City, Riyadh, Saudi Arabia.
  3. Department of Radiation Oncology, Princess Norah Oncology Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  4. Department of Surgery, Division of Urology, King Abdulaziz Medical City and King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  5. Department of Oncology, King Abdulaziz Medical City and King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
  6. Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  7. Department of Surgery, College of Medicine and Uro-Oncology Research Chair, King Saud University, Riyadh, Saudi Arabia.
  8. Department of Oncology, Section of Medical Oncology, Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  9. Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  10. Department of Urology, Prince Sultan Medical Military Center, Riyadh, Saudi Arabia.
  11. Department of Surgery, Division of Urology, Security Forces Hospital, Riyadh, Saudi Arabia.
  12. Department of Medical Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.
  13. Department of Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

PMID: 27141178 PMCID: PMC4839225 DOI: 10.4103/0974-7796.176872

Abstract

This is an update to the previously published Saudi guidelines for the evaluation, medical, and surgical management of patients diagnosed with prostate cancer. It is categorized according to the stage of the disease using the tumor node metastasis staging system 7(th) edition. The guidelines are presented with supporting evidence level, they are based on comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi oncology society and Saudi urological association. Considerations to the local availability of drugs, technology, and expertise have been regarded. These guidelines should serve as a roadmap for the urologists, oncologists, general physicians, support groups, and health care policy makers in the management of patients diagnosed with adenocarcinoma of the prostate to.

Keywords: Guidelines; Saudi oncology society; Saudi urological association; management; prostate cancer

References

  1. J Clin Oncol. 2011 Jun 1;29(16):2185-90 - PubMed
  2. JAMA. 2004 Jun 9;291(22):2713-9 - PubMed
  3. JAMA. 2008 Jun 18;299(23):2760-9 - PubMed
  4. Cochrane Database Syst Rev. 2011 Dec 07;(12):CD007234 - PubMed
  5. Urology. 1998 Mar;51(3):389-96 - PubMed
  6. Lancet. 2002 Jul 13;360(9327):103-6 - PubMed
  7. N Engl J Med. 2004 Oct 7;351(15):1502-12 - PubMed
  8. J Surg Oncol. 2014 Jun;109(8):830-5 - PubMed
  9. Urology. 1994 May;43(5):649-59 - PubMed
  10. J Clin Oncol. 2008 Jan 10;26(2):242-5 - PubMed
  11. World J Urol. 2014 Oct;32(5):1331-8 - PubMed
  12. Br J Urol. 1997 Apr;79(4):611-4 - PubMed
  13. Eur Urol. 2012 Dec;62(6):976-83 - PubMed
  14. Eur Urol. 2014 Aug;66(2):243-50 - PubMed
  15. J Urol. 2000 Sep;164(3 Pt 1):726-9 - PubMed
  16. Eur Urol. 2014 Dec;66(6):1101-8 - PubMed
  17. Urology. 2004 Dec;64(6):1182-6 - PubMed
  18. Eur Urol. 2009 Jun;55(6):1269-77 - PubMed
  19. BJU Int. 2004 Jun;93(9):1177-82 - PubMed
  20. J Clin Oncol. 2007 May 20;25(15):2035-41 - PubMed
  21. J Clin Oncol. 1999 Apr;17(4):1155 - PubMed
  22. Cancer. 2009 Aug 1;115(15):3376-8 - PubMed
  23. Cancer. 2012 Feb 15;118(4):987-96 - PubMed
  24. N Engl J Med. 2012 Sep 27;367(13):1187-97 - PubMed
  25. Urology. 2003 Dec 29;62 Suppl 1:87-94 - PubMed
  26. J Urol. 2015 Feb;193(2):491-9 - PubMed
  27. J Clin Oncol. 1993 Nov;11(11):2167-72 - PubMed
  28. Urology. 2003 Mar;61(3):607-11 - PubMed
  29. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1338-44 - PubMed
  30. J Clin Oncol. 2007 Sep 20;25(27):4178-86 - PubMed
  31. Clin Genitourin Cancer. 2015 Feb;13(1):e1-6 - PubMed
  32. Eur Urol. 2010 Jan;57(1):49-59 - PubMed
  33. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1035-41 - PubMed
  34. Eur Urol. 2011 Oct;60(4):842-9 - PubMed
  35. Ann Intern Med. 2000 Apr 4;132(7):566-77 - PubMed
  36. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):686-92 - PubMed
  37. Urology. 2000 Dec 20;56(6):1021-4 - PubMed
  38. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):134-40 - PubMed
  39. J Urol. 2008 May;179(5 Suppl):S20-4 - PubMed
  40. N Engl J Med. 2014 Mar 6;370(10):932-42 - PubMed
  41. N Engl J Med. 2013 Apr 4;368(14):1314-25 - PubMed
  42. N Engl J Med. 2004 Oct 7;351(15):1513-20 - PubMed
  43. Ann Oncol. 2015 Feb;26(2):368-74 - PubMed
  44. Lancet. 2010 Oct 2;376(9747):1147-54 - PubMed
  45. Cancer. 2008 Jun;112(11):2393-400 - PubMed
  46. Lancet. 2012 Jan 7;379(9810):39-46 - PubMed
  47. JAMA. 1999 May 5;281(17):1591-7 - PubMed
  48. Eur Urol. 2009 Jan;55(1):1-8 - PubMed
  49. J Clin Oncol. 2010 Jan 1;28(1):126-31 - PubMed
  50. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1009-16 - PubMed
  51. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1212-9 - PubMed
  52. Can Urol Assoc J. 2014 Sep;8(9-10):E702-7 - PubMed
  53. Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):104-11 - PubMed
  54. Urology. 2005 May;65(5):942-6 - PubMed
  55. Onco Targets Ther. 2014 Aug 30;7:1519-23 - PubMed
  56. BMC Cancer. 2013 Mar 19;13:131 - PubMed
  57. J Urol. 2000 Jun;163(6):1632-42 - PubMed
  58. J Clin Oncol. 2003 Nov 1;21(21):3972-8 - PubMed
  59. BMC Cancer. 2010 Dec 09;10:675 - PubMed
  60. J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68 - PubMed
  61. JAMA. 2008 Jan 23;299(3):289-95 - PubMed
  62. Urol Ann. 2011 Mar;3 Suppl:S10-6 - PubMed
  63. J Clin Oncol. 2005 Nov 10;23(32):8165-9 - PubMed
  64. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):67-74 - PubMed
  65. Urology. 2001 Apr;57(4):727-32 - PubMed
  66. BJU Int. 2004 Aug;94(3):299-302 - PubMed
  67. Eur Urol. 2014 Nov;66(5):829-38 - PubMed
  68. J Urol. 2002 Jan;167(1):117-22 - PubMed
  69. Eur Urol. 2007 Jul;52(1):29-37 - PubMed
  70. N Engl J Med. 2015 Aug 20;373(8):737-46 - PubMed
  71. J Clin Oncol. 2006 Apr 20;24(12):1868-76 - PubMed
  72. BJU Int. 2013 Jan;111(1):22-9 - PubMed
  73. Lancet Oncol. 2012 Oct;13(10):983-92 - PubMed
  74. J Clin Oncol. 1994 Sep;12(9):1868-75 - PubMed
  75. JAMA. 1998 Sep 16;280(11):975-80 - PubMed
  76. Clin Oncol (R Coll Radiol). 2014 Oct;26(10):e21-46 - PubMed
  77. Eur Urol. 2014 Nov;66(5):815-25 - PubMed
  78. Urol Ann. 2014 Oct;6(4):278-85 - PubMed
  79. Cancer. 2002 Jul 15;95(2):361-76 - PubMed
  80. BMC Urol. 2014 Jan 25;14:9 - PubMed
  81. J Urol. 2008 Sep;180(3):915-9; discussion 919-20 - PubMed
  82. N Engl J Med. 2009 Aug 20;361(8):745-55 - PubMed
  83. BJU Int. 2008 Dec;102(11):1531-8 - PubMed
  84. Cancer Invest. 1995;13(1):31-5 - PubMed
  85. Clin Endocrinol (Oxf). 2011 Mar;74(3):289-93 - PubMed
  86. N Engl J Med. 2014 Jul 31;371(5):424-33 - PubMed
  87. PLoS One. 2014 Aug 14;9(8):e104918 - PubMed
  88. J Clin Oncol. 2006 Aug 20;24(24):3984-90 - PubMed
  89. N Engl J Med. 2011 May 26;364(21):1995-2005 - PubMed
  90. J Natl Cancer Inst. 2004 Jun 2;96(11):879-82 - PubMed
  91. J Urol. 2004 Dec;172(6 Pt 1):2244-8 - PubMed
  92. Urol Ann. 2011 Mar;3 Suppl:S1-2 - PubMed
  93. Cochrane Database Syst Rev. 2000;(2):CD001526 - PubMed
  94. BJU Int. 2007 May;99(5):1056-65 - PubMed
  95. J Urol. 1993 Sep;150(3):908-13 - PubMed
  96. J Urol. 2009 Mar;181(3):956-62 - PubMed
  97. J Urol. 1994 Nov;152(5 Pt 2):1821-5 - PubMed
  98. Psychooncology. 2009 Mar;18(3):237-47 - PubMed
  99. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1012-7 - PubMed
  100. Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1443-6 - PubMed
  101. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74 - PubMed
  102. Am J Clin Oncol. 2011 Apr;34(2):140-4 - PubMed
  103. Clin Radiol. 2008 Apr;63(4):387-95 - PubMed
  104. N Engl J Med. 2012 Sep 6;367(10):895-903 - PubMed
  105. Eur Urol. 2008 Aug;54(2):382-91 - PubMed
  106. Cancer. 2003 Feb 15;97(4):1127-33 - PubMed
  107. Lancet Oncol. 2010 Nov;11(11):1066-73 - PubMed
  108. N Engl J Med. 2013 Jan 10;368(2):138-48 - PubMed
  109. Lancet Oncol. 2015 Feb;16(2):152-60 - PubMed
  110. Lancet. 2005 Aug 13-19;366(9485):572-8 - PubMed
  111. J Urol. 2003 Nov;170(5):1798-803 - PubMed
  112. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1097-105 - PubMed
  113. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1285-90 - PubMed
  114. J Clin Oncol. 2004 Mar 15;22(6):1025-33 - PubMed
  115. Lancet. 2011 Mar 5;377(9768):813-22 - PubMed
  116. J Urol. 2007 Oct;178(4 Pt 1):1290-5 - PubMed
  117. JAMA. 2005 Sep 14;294(10):1233-9 - PubMed
  118. N Engl J Med. 2013 Jul 18;369(3):213-23 - PubMed
  119. Cochrane Database Syst Rev. 2014 Jun 30;(6):CD009266 - PubMed
  120. N Engl J Med. 1994 Jan 27;330(4):242-8 - PubMed
  121. J Urol. 2007 Aug;178(2):493-9; discussion 499 - PubMed
  122. JAMA. 2004 Mar 17;291(11):1325-32 - PubMed
  123. J Clin Oncol. 2005 Nov 10;23(32):8192-7 - PubMed
  124. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1243-52 - PubMed
  125. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):415-9 - PubMed
  126. Lancet. 2000 Apr 29;355(9214):1491-8 - PubMed
  127. J Clin Oncol. 2000 Dec 1;18(23 ):3904-11 - PubMed
  128. Cancer. 2009 Aug 1;115(15):3437-45 - PubMed
  129. Brachytherapy. 2010 Apr-Jun;9(2):119-25 - PubMed
  130. Int J Clin Pract. 2004 Apr;58(4):382-90 - PubMed
  131. Eur Urol. 2010 Mar;57(3):437-43 - PubMed
  132. Can Urol Assoc J. 2013 May-Jun;7(5-6):E263-7 - PubMed
  133. JAMA. 1993 Jan 6;269(1):57-60 - PubMed
  134. N Engl J Med. 1997 Jul 31;337(5):295-300 - PubMed
  135. J Urol. 1998 Oct;160(4):1387-91 - PubMed
  136. BJU Int. 2012 Nov;110(9):1262-9 - PubMed
  137. JAMA. 1998 Sep 16;280(11):969-74 - PubMed
  138. BJU Int. 2012 Dec;110(11):1672-7 - PubMed
  139. J Urol. 2003 Dec;170(6 Pt 1):2292-5 - PubMed
  140. J Urol. 2008 Sep;180(3):921-7 - PubMed

Publication Types